NEW

Aspen Surgical Acquires Protek Medical Products

Aspen Surgical Products Inc. has announced its acquisition of Protek Medical Products Inc. Based in Coralville, Iowa, Protek is a global manufacturer of single-use ultrasonic probe covers and needle guides used in tissue biopsies, fluid aspiration and vascular access...

Exactech Sharpens Focus on Technology with Active Intelligence

Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, has announced the launch of its Active Intelligence® platform of technologies that spans the entire journey of patient care.

New BioPledge Bleach And Alcohol-Free Daily Disinfectant Approved By EPA For Use Against COVID-19 Virus

BioPledge LLC announced today the U. S. Environmental Protection Agency (EPA) approval of BioPledge® Antimicrobial POWER™ healthcare disinfectant for kill claims against SARS-CoV-2, the novel coronavirus that causes COVID-19, on hard non-porous surfaces. The new multi-purpose disinfectant and cleaner has been added to the EPA’s List N under EPA Reg No. 91691-1.

RCSI, BD Expand Access to Pediatric Surgery in Sub-Saharan Africa

The RCSI Institute of Global Surgery and global medical technology company, BD (Becton, Dickinson and Company) announce KidSURG, a joint initiative aimed at significantly improving pediatric surgical services across Southern Malawi.

Clinical Trial to Study Impact of ActivePure Technology on Surgical Site Infections

A randomized multiple crossover cohort quality improvement Trial

Aerus Medical Guardian with ActivePure TechnologyNEW YORK (Nov. 18, 2020) – Aerus Medical formally announced the start of a double-blind 2-year clinical study to evaluate the impact the Aerus Medical Guardian with ActivePure Technology can have on reducing nosocomial infections, or healthcare-associated infections – HAIs, from surgical operating room procedures.

Aerus Medical Guardian with ActivePure Technology, a Food and Drug Administration Class II Medical Device, reduces bacteria and viruses in the air by 99.99% within 30 minutes and surface contamination by more than 99% after several hours. The primary goal of the randomized trial will be to determine whether filtering and sterilizing operating room air with the Aerus Medical Guardian with ActivePure Technology air purifier reduces a composite of serious surgical site infections, infection-related complications and death within 30 days after surgery. Secondarily, the trial will determine the effect of air filtration and sterilization on serious surgical site infections and on the cost of care.

HAIs are a significant concern that can have serious medical, emotional and financial consequences. These types of infections cost the U.S. health care systems billions of dollars each year. According to the Centers for Disease Control and Prevention, on any given day about one in 31 hospital patients has at least one HAI.

“Complications from surgical wound infections are a major concern for hospital systems everywhere,” said Joe Urso, president and CEO of Dallas-based Aerus Holdings. “Combined with our previous infection control studies, …”

The Aerus Medical Study will use 50 noncardiac, adult operating rooms at Cleveland Clinic. The trial will be restricted to adults aged 18 years or older, having surgery lasting at least one hour. Patients with present-on-admission infections will be excluded from the study. Operating rooms will be randomized in one-month blocks to Aerus air sterilization or conventional air handling. A minimum of 67,653 patients with a maximum of 86,639 patients will be needed for this study.

The trial is expected to begin this year and last approximately two years.

The Aerus Medical Guardian with ActivePure Technology is roughly the size and configuration of carry­on luggage (26.5″H x 11.5″W x 21.0″D) and weighs 48 pounds. It cleans 18,000 cubic feet of air per hour on its “high” setting. The system actively cleans the air with activated carbon, ActivePure Molecules and high-efficiency particulate filtration.

The Aerus Medical study is sponsored by Aerus Medical LLC, the company that developed the surface and air purification unit Aerus Medical Guardian with ActivePure Technology.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X